NIBAN1 and carcinoma: FAM129A is highly expressed in carcinomas including thyroid carcinomas66,67 and is used as one of several markers that may differentiate benign from malignant thyroid lesions, therefore, it is considered to be the best predictor for thyroid cancer68–71.